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Abstract
Understanding the complex population biology and transmission ecology of mul-
tihost parasites has been declared as one of the major challenges of biomedical
sciences for the 21st century and the Neglected Zoonotic Diseases (NZDs) are
perhaps the most neglected of all the Neglected Tropical Diseases (NTDs). Here
we consider how multihost parasite transmission and evolutionary dynamics may
affect the success of human and animal disease control programmes, particularly
neglected diseases of the developing world. We review the different types of zoo-
notic interactions that occur, both ecological and evolutionary, their potential
relevance for current human control activities, and make suggestions for the
development of an empirical evidence base and theoretical framework to better
understand and predict the outcome of such interactions. In particular, we con-
sider whether preventive chemotherapy, the current mainstay of NTD control,
can be successful without a One Health approach. Transmission within and
between animal reservoirs and humans can have important ecological and evolu-
tionary consequences, driving the evolution and establishment of drug resistance,
as well as providing selective pressures for spill-over, host switching, hybridiza-
tions and introgressions between animal and human parasites. Our aim here is to
highlight the importance of both elucidating disease ecology, including identify-
ing key hosts and tailoring control effort accordingly, and understanding parasite
evolution, such as precisely how infectious agents may respond and adapt to
anthropogenic change. Both elements are essential if we are to alleviate disease
risks from NZDs in humans, domestic animals and wildlife.
Introduction
At the beginning of the twenty-first century, the world is
faced with a changing landscape of infectious diseases that
affect both humans and animals, many of which can pose
significant threats to health and welfare. Threats from old
and new parasites and pathogens continue to emerge,
fuelled by changes in the environment (climate, dam con-
structions, deforestation, disruption of ecosystems, etc.), in
agriculture and food production (from intensive systems of
husbandry and farming monoculture to changing of tradi-
tional patterns of livestock movements), and in the demog-
raphy and connectivity of the modern ‘global’ village
(population growth, urbanization, international trading,
world tourism and rapid transportation) (Gibbs 2005;
Johnson et al. 2015). Anthropogenic changes, particularly
those involving movements of infected people and animals
or that change habitats in a manner likely to provide new
opportunities for host-parasite mixing, can further drive
the introduction of both known and novel parasite geno-
types to previously unaffected host individuals or species.
In recent years, the emergence or re-emergence of animal
and human infectious diseases has been increasingly docu-
mented around the world (Woolhouse et al. 2005), with an
© 2015 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
313
Evolutionary Applications ISSN 1752-4571
Evolutionary Applications
average of three new human infectious diseases being
reported approximately every two years, and a new infect-
ing organism described every week (http:/www.gideonon-
line.com) (Tomley and Shirley 2009). Ancient diseases,
such as schistosomiasis (Berry et al. 2014; ECDC 2014;
Laval et al. 2014; Boissier et al. 2015), are also presenting
in novel environments and causing new or changing pat-
terns of disease as human populations and their environ-
ments grow and change. Attempts to control infectious
agents through large-scale drug distribution or vaccination
also add to the ever-changing environment in which para-
sites and pathogens must either evolve, adapt or succumb
(Webster et al. 2008, 2014).
At least 60% of human diseases and 60–75% of new
emerging diseases are multihost zoonoses (Cleaveland et al.
2001). Zoonotic reservoirs can maintain infections in times
of change, thwart attempts to control or eliminate disease
in human populations, as well as influence parasite evolu-
tion by providing opportunities for host switching or
genetic exchange giving rise to novel genetic combinations.
The World Bank has estimated that zoonoses have cost glo-
bal economies more than $20BN in direct, and $200BN in
indirect, costs between 2000 and 2010. Zoonotic disease
risks are predicted to further increase as environmental
change continues. The global human population is
expected to increase from approximately 7.2 billion in 2014
to approximately 9.2 billion by 2050, with around one bil-
lion of this increase occurring in Africa alone (UNDP
2008). Standing populations of livestock in 2007 were esti-
mated at 1.43 billion cattle, 1.87 billion sheep and goats,
0.98 billion pigs and 19.6 billion chickens, with average
yearly increases of 5.1% and 3.6% in developing country
meat and dairy sectors, respectively, since 1970 (WHO
2012a; Robinson et al. 2014).
The ‘megacities’ of the world constitute obvious melting
pots for the mixing of human and animal parasites and
their potential rapid spread, both locally and internation-
ally. For instance, although transmission of SIV from chim-
panzees to humans may have occurred on a number of
distinct occasions (Hahn et al. 2000), such spill-overs
(Table 1) remained isolated and only through urbanization
and increased global travel did the HIV pandemic take off
in the 20th century (Fenton and Pedersen 2005). Urbaniza-
tion and large-scale human population movements, often
associated with conflict, have similarly been implicated in
more recent outbreaks of potentially zoonotic origin dis-
eases from leishmaniasis (Saroufim et al. 2014) to Ebola
(Faye et al. 2015). However, rural landscapes also pose ever
increasing risks for the mixing of human and animal para-
sites, especially those exposed to recent anthropogenic
changes such as new dam construction, flooding and
changes in animal husbandry. The Food and Agriculture
Organization estimates that livestock contributes to the
livelihoods of 70% of the world’s rural poor (WHO 2006).
Not only are poor people and their livestock more at risk of
contracting a range of zoonoses, once infected, it is the
poor that are least likely to have access to health services
and hence get appropriate medical or veterinary care.
The Neglected Tropical Diseases (NTDs) are highly
debilitating diseases caused by a range of viruses, bacteria,
protozoa and helminths which infect more than one billion
people, a sixth of the world’s population, but predomi-
nantly the poorest of the poor (Hotez et al. 2009). An ini-
tial assessment suggested that 14 of the major NTDs kill an
estimated 534 000 people worldwide every year, while
causing a disease burden measured in Disability-Adjusted
Life Years (DALYs) that competed with HIV/AIDS, tuber-
culosis and malaria (Hotez et al. 2006). However, as the
name suggests, NTDs have been identified as diseases that
receive less attention and funding compared to those other
diseases (Liese et al. 2014). We are, however, currently in
an exciting era of disease control, at least with respect to
several of the human NTDs (Webster et al. 2014). A subset
of seven NTDs are being targeted with preventive
chemotherapy through Mass Drug Administration of
inexpensive, effective, oral drugs in affected communities
(Table 1). The term ‘preventive chemotherapy’ was intro-
duced by the WHO to define the strategic approach of
treating populations infected, or at risk of being infected,
with these NTDs without the need for individual diagnosis
(WHO 2006). Some of these diseases have already been tar-
geted for elimination (e.g. lymphatic filariasis, onchocercia-
sis and trachoma), while successful morbidity control
against others (e.g. schistosomiasis and soil-transmitted
helminthiasis (STH)) has recently also shifted the current
agenda towards ‘elimination as a public health problem by
2020’ (WHO 2012b; Webster et al. 2014).
Neglected Zoonotic Diseases (NZDs) are a critically
important subset of the NTDs. Zoonoses are diseases that
are naturally transmitted between vertebrate animals and
humans, a process that increases the potential complexity
of developing sustained and effective control, and demands
a One Health perspective. While control programmes to
date tend to be human focused only (notwithstanding the
use of vector control in certain settings), the WHO Depart-
ment of Control of NTDs has identified rabies, taeniasis/
cysticercosis, zoonotic human African trypansomiasis,
echinococcosis and food-borne trematodiases as priority
NZDs, with the potential to target control at both human
and animal hosts (Table 1). Moreover, many of the drugs
used in human treatment programmes are also active
against nontarget parasite species, some of which infect ani-
mals. For example, praziquantel, used in human schistoso-
miasis control, is also active against the food-borne
trematodes paragonimiasis, opithorchiasis and fasciololaiasis,
as well as echinococcus and taenia/cysticercosis, all of
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Table 1. Human-targeted versus Animal-targeted control measures for some of the major NZDs and NTDs.
Disease Infectious agents Known Animal Host Reservoirs
Current Human- focused
control Current Animal-focused control
Schistosomiasis Urogenital form:
Schistosoma
haematobium
Intestinal from:
S. mansoni,
Schistosoma
japonicum,
S. mekongi or
S. intercalatum.
S. japonicum: Large number of
domestic and wildlife
reservoirs – in particular
bovines and rodents,
respectively; S. mansoni:
baboons, rats
S. haematobium: was assumed
human-specific, but
S. haematobium-group
introgressed hybrids suspected
within livestock and
potentially wildlife, currently
under investigation
Preventive chemotherapy with
praziquantel across parts of
sub-Saharan Africa, Asia, the
Arabian Penisular, and South
America
Focal mollusciciding in some
settings, for example China
and Zanzibar
Preventative chemotherapy with
praziquantel and vaccine under
development for S. japonicum
in bovines only in China.
Elsewhere no animal-focused
control
Soil-transmitted
helminthiasis
Ascaris lumbricoides
Necator americanus
Ancylostoma
duodenale
A.ceylanicum
Trichuris trichuria
Pigs
Dogs, cats, wild canids
Baboons; pigs? Dogs?
Preventive chemotherapy with
albendazole or mebendazole
Ivermectin used for
onchocerciasis control will
also impact on STH
Regular de-worming of pet dogs
and cats in developed
countries; No organized
control in developing countries
Lymphatic
filariasis
Wuchereria bancrofti
Brugia malayi/
B. timori
Cats and leaf monkeys
(Presbytis) can be infected
with Brugia malayi although
significance unknown
No known animal reservoirs for
W. bancrofti
Annual Preventive
chemotherapy with
Ivermectin and albendazole
or albendazole with
Diethylcarbamizine
Vector control in Anopheles
transmitting settings in Africa
and Papua New Guinea
No
Onchocerciasis Onchocerca volvulus None known, although related
species in cattle, for example
O. gutturosa
Preventive chemotherapy with
Ivermectin
No (but no animal hosts
confirmed)
Trachoma Chlamydia trachomitis None known, although closely
related species in animals;
thought to be separate species
Preventive chemotherapy with
azithromycin
No (but no animal hosts
confirmed)
Dengue fever Dengue virus Primates Vector control No
Chagas disease Trypanosoma cruzi Domestic transmission cycles:
dogs, cats
Sylvatic transmission cycles:
over 180 small mammal
species particularly rodents,
bats and Opossums
(peri-domestic reservoir)
Domestic & sylvatic cycles
overlap in some regions
Vector control No
Human African
Trypanosomiasis
Trypaonsoma brucei
gambiense
T.b. rhodisiense
Pigs, cattle, squirrels,
porcupines, monkeys
potentially pigs.
Wild ungulates, cattle,
Active surveillance to detect
cases and treat; vector control
Case finding and treatment
Not for T. b. gambiense
Chemotherapy of cattle
reservoir (Uganda)
accompanied by selective
spraying of insecticides
on cattle
(continued)
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Table 1. (continued).
Disease Infectious agents Known Animal Host Reservoirs
Current Human- focused
control Current Animal-focused control
Leishmaniaisis Leishmania infantum,
L.donovani (viscercal
leishmaniasis)
Up to 15 Leishmania
spp. inc. L. major &
L. tropica (cutaneous
leishmaniasis)
Dogs
No known reservoir of
L.donovani in Asia
Rodents (Africa & EurAsia &
Americas)
Improved diagnostic methods
for case identification aim to
increase access to drugs and
decrease drug prices.
Case detection through
improved diagnostics. Vector
control through indoor
residual spraying
Some case detection in dogs in
developed countries. Use of
insecticide impregnated collars
or pour –on insecticides for
treatment of dog reservoirs
For L. major in North Africa,
Middle east/ Central Asia
destruction of rodent habitats
and vegetation on which
reservoir rodents dependent
Rabies Rabies virus (a lassa
virus)
Dogs and wild canids, cats,
horses, mongooses, primates,
racoons, sheep, skunks and
wolves.
Health education. Availability
of postexposure prophylaxis
vaccines
Systematic culling of feral and
domestic dogs in some regions
(e.g. Philippines)
Mass vaccination of dogs, for
example South America,
KwaZulu-Natal province of
South, Bali, Indonesia
Cystercercosis
taeniasis
Taenia solium Pigs Individual treatment with
praziquantel –
Plans for preventive
chemotherapy in progress
Meat inspection; health
education
Treatment and/or vaccination of
pigs in planning stages
Guinea worm -
Dracunculiasis
Dracunculus
medicinsis
Dogs and potentially
also cats
Temephos treatment of water
bodies to kill copepod
intermediate hosts; filtering
of potentially contaminated
water; provision of safe
drinking water sources;
case containment of new
cases to prevent access to
water bodies
Case detection of dogs in Chad
recently initiated; reward for
reporting infected dogs;
tethering dogs to prevent
access to water bodies
Food-borne
trematodiasis
Paragonimus spp.
Opisthorchis viverinni
O. felineus.
Clonorchis spp.
Fasciola hepatica and
F. gigantica
Dogs, cats, wildlife
Cats, dogs, wildlife
Cats, dogs, foxes, pigs
Cats, dogs, fish-eating
mammals
Cattle, sheep, buffalo, donkeys,
pigs, other herbivores
‒ Individual treatment with
PZQ or triclabendazole
Mass screening in some areas
No
Buruli ulcer Mycobacterium
ulcerans
Unknown Early diagnosis and antibiotic
treatment
Surgery of advanced lesions
No (but no animal hosts
confirmed)
Leprosy Mycobaterium leprae Armadillos, nonhuman
primates
Multidrug therapy available
free of charge from WHO
for all endemic countries
No
Yaws Treponema pallidum None known- but Treponema
sp. present in nonhuman
primates
Antibiotic treatment No (but no animal hosts
confirmed)
Anthrax Bacillus anthracis Domestic and wild herbivores Vaccination and antibiotic
treatment
Vaccination and antibiotic
treatment
Bovine TB Mycobaterium bovis Wide range of mammalian
hosts
BCG vaccination in some
developed countries
Systematic culling of domestic
and wildlife in developed
countries
No or limited control in
developing countries
(continued)
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which are zoonotic (Table 1). In fact, many, if not all, of
the drugs currently used to treat human NTDs are the same
as those used treat animal diseases and indeed were initially
developed for veterinary use (Table 1). The use of these
drugs in humans may therefore also affect parasites in ani-
mal populations, with potential feedbacks to human dis-
ease through zoonotic transmission. The broader scale
community dynamics, in terms of selective pressures placed
on the infectious agents, though rarely studied, could have
profound impacts on their potential for evolution and
spread. For instance, mismanagement of anthelminthics in
animals increases the risk of drug resistance evolving,
thereby making drugs against zoonotic diseases no longer
available to humans.
We are also in an exciting time in terms of improved
molecular and diagnostic tools. Genetic and genomic data
have become increasingly important in identifying and
characterizing zoonotic parasites, and a proliferation of
cross-host species interactions have recently been revealed,
which may have substantial implications from both epi-
demiological and evolutionary perspectives (King et al.
2015; Lamberton et al. 2015). Analysis of molecular
sequence data and population genetics also offers unprece-
dented opportunities to understand micro-evolutionary
processes and the response to selection of such infections,
as well as to elucidate relationships and genetic exchange
between the parasites that infect different host species. For
example, analyses of supposed ‘human-specific’ and ‘ani-
mal-specific’ species have revealed instances of ‘cryptic’ or
‘covert host specificity’, where parasites previously charac-
terized as generalists (capable of infecting many host spe-
cies), have turned out to rely heavily on single-host species,
and populations of relatively host-specific strains circulate
independently in different host species. Examples of pre-
sumed generalist pathogens that have since been shown to
have cryptic host specificity include rabies virus in bats
(Streicker et al. 2010) and parasitoid flies of insects (Smith
et al. 2006). Conversely, molecular sequencing has now
also revealed several instances of ‘covert generalists’, where
parasites thought to be different because they were initially
diagnosed in different host species turn out to be the same.
For example, there are the morphologically similar species
of Ascaris nematodes in pigs (A. suis) and humans (A. lum-
bricoides), which occur sympatrically in many foci. Betson
and colleagues (Betson et al. 2014) conducted a molecular
study of Ascaris in pigs and humans from across Europe,
Africa, Asia and Latin America and found that while there
was indeed marked genetic segregation between worms
originating from human and pig hosts, human Ascaris
infections in Europe were found to be of pig origin and
there was evidence of cross-transmission between humans
and pigs in Africa (Betson et al. 2014). The authors thus
concluded that cross-transmission of Ascaris between
humans and pigs can occur in both developing and
developed countries, with differing zoonotic interactions
contingent upon epidemiological potential and local phylo-
geography. Similarly, there has been a continuing contro-
versy about the taxonomic status of Trichuris suis from pigs
and Trichuris trichuria in humans, and whether pigs are a
zoonotic source of human infection. Cutillas et al. (2009)
concluded that while they are separate parasite species
based on ITS1 & ITS2 sequences, cross-infection between
host species do occur.
Understanding the complex population biology and
transmission ecology of multihost parasites has been
declared as one of the highest priorities for biomedical
sciences for the 21st century (Woolhouse and Dye 2001;
Woolhouse et al. 2001, 2002) and multihost zoonotic dis-
eases are perhaps the most neglected of all the neglected
diseases (Webster et al. 2014). Furthermore, seldom are the
potential evolutionary responses by parasites considered
within control programmes. Such responses may be exacer-
bated when we recognize that focal parasite and host spe-
cies are embedded within a wider community of host and
parasite species, which may greatly alter parasite gene flow
through the community, enhance or diminish selection
pressures imposed on parasites, and even result in the
emergence of novel hybrid parasite species (Fig. 1). Clearly
Table 1. (continued).
Disease Infectious agents Known Animal Host Reservoirs
Current Human- focused
control Current Animal-focused control
Brucellosis Brucella sp. Domestic animals esp cattle &
goats, wildlife, dogs
Health education on risk of
contact with livestock/
products
Vaccination of cattle in
developed countries
Cystic
echinococcus
Alveolar
echinococcosis
Echinococcus
granulosus
E. multilocularis
Dog, sheep, goats, camels, yak,
cattle camels
Rodent reservoirs
Health Education
on dog role and slaughter of
sheep
Vaccination of lambs promising.
Deworming of dogs
Appropriate disposal of offal
containing cystic stages and
preventing access of carnivores
to cystic stages
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a more complete, One Health perspective, of the ecological
and evolutionary settings of multihost zoonotic diseases is
needed if we are to develop effective, sustained disease
management strategies for these neglected diseases. Here,
we address these issues by reviewing the different types of
zoonotic interactions that may occur, the potential evolu-
tionary impact of current human control activities such as
preventive chemotherapy, and make suggestions for the
development of an empirical evidence base and theoretical
framework to better understand and predict the likelihood
and outcome of such interactions.
Understanding zoonotic disease transmission: the
need to identify and characterize ‘key hosts’
While much epidemiological theory uses a single-host–sin-
gle-parasite framework, in reality most diseases globally,
including emerging and re-emerging diseases in humans,
involve multiple hosts (Cleaveland et al. 2001; Pedersen
and Davies 2009). Animal reservoirs can maintain trans-
mission with zoonotic parasites, even while the disease they
cause in humans is effectively controlled (Box 1; Table 1).
This is common and not restricted to tropical diseases, with
examples such as the maintenance of bovine TB by reser-
voir hosts including, but not necessarily exclusive to, bad-
gers in the UK (Mathews et al. 2006). The epidemiology of
multihost parasites can involve a complex community of
reservoir and vector species, and where infected hosts may
range from spill-over to maintenance hosts and from rela-
tive specialist parasites to true multihost generalists
(Box 1). Within this context, the importance of differing
hosts may vary and it is imperative, if often difficult, to
identify which is which. Each host species is unlikely to
contribute equally to parasite transmission, as they differ in
abundance, exposure and susceptibility, and the transmis-
sion pathways among them (Haydon et al. 2002; Fenton
et al. 2015). Even parasites with a very broad host range
often occur or are transmitted predominantly by just a sub-
set of potential hosts, or ‘key host’ species (Box 1). More-
over, for a given zoonotic parasite, the relative importance
of different host species, that is the key hosts, can vary
across ecological settings. These host species (which can
also refer to intermediate host and vector species (Moly-
neux 2003)) not only act as a source of parasitic infections
but also play a fundamental role in driving parasite gene
flow through the community. Therefore, they can act as a
driver of evolutionary change, but also potentially be a
source of genetic bottlenecking within the parasite popula-
tion. Due to both the clear importance of understanding
such heterogeneities in disease transmission across host
communities (for instance, for effective control, we would
need to identify which species are important for amplifying
transmission and transmitting to target host populations),
and the likelihood that evolutionary selective forces may
differ between such hosts and environments, it is thereby
imperative to first identify key host species acting as reser-
voirs of infection (Haydon et al. 2002). However, to fully
understand and predict the transmission dynamics of any
infection, it is also essential to know the relative contribu-
tion of any particular host species to the transmission
dynamics of the parasite (Rudge et al. 2013; Fenton et al.
2015) and the importance of the host species to the evolu-
tionary pressures acting on the parasite. At the extreme,
multihost parasites may depend on a single species for
long-term persistence, a ‘maintenance’ key host (Box 1).
Being able to identify these key hosts is essential in deter-
mining which host species to target for disease control
(Haydon et al. 2002; Fenton and Pedersen 2005). For
example, rabies virus infections in wild carnivores in the
Serengeti depends on viral maintenance by domestic dogs,
so vaccinating dogs is expected to alleviate epizootics in
wildlife (Lembo et al. 2008). Consequently, interventions
such as vaccination, culling or sterilization commonly tar-
get single species rather than all infected hosts. However, it
is also important to consider the distinct processes by
Parasite 
species 1
Parasite 
species 2
Host 
species A
Host 
species B
Figure 1 Schematic representation of a general multihost – multipara-
site scenario. Parasite species 1 is the focal parasite of interest, and is a
generalist (see Box 1 glossary) able to infect both host species A and B.
However, host species B is the key host species for this parasite, domi-
nating transmission. In the extreme, if host species B is a maintenance
host and species A is not then, in the absence of any evolutionary
response by the parasite, treating host species B will result in elimination
of parasite species 1. However, parasite 1 may be able to evolve in
response to that treatment, either by evolving resistance to the treat-
ment, or undergoing a host shift to be maintained on host species A. In
the scenario shown this would then expose it to possible co-infections
with parasite species 2. Parasite species 2 could act to facilitate or sup-
press the likelihood of species 1 establishing in the new host and, if the
two parasite species are sufficiently related, could result in hybridization
and/or introgression between them.
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Box 1. Glossary of Transmission Terms
Term Definition
Apparent Multihost Parasite Infections occurring in more than one host species that arise from frequent cross-species transmission
from a maintenance host species or population to a nonmaintenance host species or population (Fenton
and Pedersen 2005). Due to the high frequency of cross-species transmission, infections in the
nonmaintenance host are continuously observed, unlike in the case of ‘spill-over’ infections. As with spill-
over infections though, removal of the maintenance host, or blocking of cross-species transmission,
would cause infections in the nonmaintenance host species to fade out.
Critical Community Size (CCS) The minimum threshold population size for a host species to maintain parasite infection; only those host
species with a population size in excess of the CSS will be capable of independent sustainment of
transmission in the absence of other host species (Viana et al. 2014). Maintenance hosts, by definition,
have population sizes in excess of the CSS, whereas nonmaintenance hosts do not.
Cryptic host specificity Where apparently generalist parasites, which appear to infect multiple host species, actually comprise
distinct subspecies or strains that circulate within each host species independently of each other. Cryptic
host specificity is increasingly being revealed through increasing use of genetic sequencing.
Dead End Hosts Host species that can become infected by a given parasite, but are not able to transmit those infections
onwards to other individuals.
Generalist parasite In the broadest definition, a parasite that is capable of infecting more than one host species, whether or
not it is able to transmit onwards from, or be maintained by, each host species. There may be different
types of generalist parasites, depending on their ability to transmit onwards from the different host
species (if they cannot, then those species are deemed to be dead end hosts), or be maintained by those
different host species in the absence of transmission from other host species (i.e. maintenance host
species). Generalist parasites that have multiple maintenance host species are deemed to be true multi-
host parasites.
Host switching or Host shift Where a parasite jumps from one host species to another. Host shifts appear to be common, with the
phylogenies of hosts and parasites often showing incongruence, suggesting parasites have switched
between host species. Past host switches within a group of parasites are often inferred from a
comparison of the parasite phylogeny with that of the hosts. Congruence between the phylogenies is
often attributed to a history of association by descent with co-speciation, and incongruence to host
switching or extinction in ‘duplicated’ parasite lineages, which diverged without a corresponding
branching of the host tree.
Hybridization From a taxonomic perspective, hybrid refers to offspring resulting from the interbreeding between two
animal species or plant species – usually between species in the same Genera. An intraspecific hybrid
may refer to crosses between subspecies or different populations of the same species.
Introgressive hybridization Introgression, also known as introgressive hybridization, in genetics it is the movement of a gene (gene
flow) from one species into the gene pool of another by the repeated backcrossing of an interspecific
hybrid with one of its parent species. Introgression is an important source of genetic variation in natural
populations and may contribute to adaptation and even adaptive radiation. Introgression differs from
simple hybridization. Introgression results in a complex mixture of parental genes, while simple
hybridization results in a more uniform mixture, which in the first generation will be an even mix of two
parental species.
Key host From ‘keystone’ ‒ something on which other things depend on, in this case the infectious agent. Even the
most generalist of parasites often predominantly infect, and transmit from, a subset of potential hosts.
Host species (where host here also included intermediate hosts and/or vector species (Molyneux 2003))
that individually contribute significantly to long-term parasite persistence, and drive infection risk in
sympatric host species relative to other host species, may be deemed to be key hosts. Key hosts can arise
through different mechanisms (i.e. super-abundant, super-infected or super-shedding, which may be
due to innate differences among the species (i.e. genetic compatibility), co-infection by other parasite
species facilitating infection and transmission by the focal parasite, or may even arise through
behavioural modification by the parasite to facilitate super-infectivity. These different types of key host
can have important implications for the optimal targeting of control. Hence, not only identifying key host
species, but identifying which kind of key host species they are, is imperative for optimal targeting of
control strategies.
(continued)
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which host species contribute differentially to parasite
transmission and maintenance, and the different ways in
which key hosts can arise, a feature that has received rela-
tively little attention (Streicker et al. 2013). A host species
can make disproportionate contributions to the total infec-
tious pool by being, for instance, ‘super-abundant,’ ‘super-
Box 1 . (continued).
Term Definition
Maintenance host A population (or community) that is capable of sustaining a parasite, independent of epidemiological
input from elsewhere (Haydon et al. 2002). A maintenance host population has a population size in
excess of the Critical Community Size (CSS), the minimum density required to sustain the parasite (Viana
et al. 2014). In deterministic models this equates to the basic reproduction number R0,i exceeding 1,
although this criterion is not always sufficient for parasite persistence where, for example, parasites with
R0 > 1 may be lost through stochastic fade out (Lloyd-Smith et al. 2005). A nonmaintenance host
population is unable to maintain the parasite in the absence of external input, and so has a population
size below the CSS.
Paratenic Host A host that is not necessary for the development of a particular species of parasite or pathogen, but can
serve to maintain the life cycle of that parasite/pathogen. In contrast to its development in an
intermediate, secondary or definitive host, a parasite in a paratenic host does not undergo any
subsequent changes in its development.
Potential Emerging Infectious Disease A parasite that would be capable of infecting a novel host species, but is prevented from doing so purely
through an ecological or host-behavioural barrier to exposure (Fenton and Pedersen 2005). If that barrier
is breached (for example, through anthropogenic change that facilitates contact between species), the
infection will take off in the previously na€ıve host population.
Refugia In parasitology Refugia refers to the parasite population that have not been exposed to a particular drug
and hence still contains a large proportion of susceptible organisms. Having a large Refugia lessens the
selective pressures placed on the parasite for the evolution of drug resistance. Refugia in terms of mass
drug administration may relate to the human populations not treated, but also in terms of animal
reservoirs of infection not exposed to drug treatment programmes.
Reservoir Host One (or more) host populations in which a parasite can persist, and which acts as a source of infection to
a target Host species (Haydon et al. 2002). Some reservoirs can be simple and comprise a single
nontarget host population. However, reservoirs of infection can be ecologically complicated structures
comprising one or more interacting host species in which a parasite can be permanently maintained and
from which infection is transmitted to the target host population.
R0, the basic reproduction number A parasite’s fitness can be measured by its basic reproduction number, or R0, which is defined as the
number of new infections (for a microparasite, such as a virus, bacteria or protozoan) or new adult
parasites (for a macroparasite, such as a helminth or ectoparasite) arising from a primary infection in a
wholly susceptible host population or community. This definition provides a threshold for parasite
invasion into a na€ıve host population; if R0 > 1, then the parasite can invade, if not then the parasite
cannot. In deterministic models this also equates to the condition for parasite persistence within that
host population. In a multi-host species context, the overall R0 of the parasite within the community
(R0,TOT) depends on the combined contributions of each of the i host species; R0,i (Fenton et al. 2015;
Dobson 2004).
Spill-over Host A nonmaintenance host population which encounters occasional cross-species transmission from a
maintenance host population or reservoir. Unlike apparent multi-host parasitism, spill-overs cause
transient infections in the spill-over (nonmaintaining) host population. Removal of the maintenance host,
or blocking of cross-species transmission, would cause infections in the nonmaintenance host species to
fade out.
Target host or Target host population The study of epidemiology is often motivated by the need to control disease in a particulate host
population (e.g. a human population) or subset of a population. This can be referred to as the target host
or target host population that may be risk of infection from a Reservoir or Source population.(Haydon
et al. 2002; Viana et al. 2014); it may or may not be a maintenance host population in its own right.
True Multihost Parasite Infections in multiple host species that are able to be maintained by those species in the absence of any
other host species. Cross-species transmission may occur, but is not essential for parasite maintenance in
either host species. Removal of either host species, or blocking of cross-species transmission, would not
lead to loss of infection from the other host species, although prevalence may decline if rates of
cross-species transmission were significant (Fenton and Pedersen 2005).
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susceptible’, ‘super-infected’ and/or a ‘super-shedder’. That
is, the relative contribution of any individual host species
to a parasite’s total transmission pool is proportional to the
product of that species’ abundance, infection and shedding
(Streicker et al. 2013). For instance, the importance of dogs
for rabies transmission is driven at least partly by their
higher population densities relative to other carnivore spe-
cies (Lembo et al. 2008), but West Nile virus transmission
around Washington D.C. is dominated by the presence of a
relatively rare, but highly infectious bird, the American
robin (Kilpatrick et al. 2006). Furthermore, certain host
species may have behavioural patterns that make them key
hosts, where even if not, for instance, highly abundant,
their behavioural repertoires place them in high contact
with humans and/or other suitable host species. There are
numerous cases of such behavioural alternations and modi-
fications within parasitized invertebrate, including vector,
host species, although vertebrate host cases are rarer
(Adamo & Webster, 2013). One example may be the roost-
ing behaviour and habitat selection of bats and their link to
Nipah virus epidemiology (Hahn et al. 2014). Even more
intriguing are cases where certain indirectly transmitted
parasites can adaptively manipulate host behaviour in a
manner to enhance transmission. Prime examples of such
manipulation include the increased aggression proposed to
enhance transmission via biting of viruses such as rabies,
Hantaan and Seoul viruses through blood and saliva
(Kaushik et al. 2012) to the subtle ‘mind’ alteration of
infected rodents by Toxoplasma gondii, that enhances pre-
dation by its feline definitive host and therefore transmis-
sion (Webster 2007; Webster et al. 2013b; Kaushik et al.
2014).
While for many NZDs it remains poorly understood
how different host species contribute to transmission and
human infection, studies of schistosomiasis in Asia illus-
trate how knowledge about key hosts can inform disease
control. Both Schistosoma japonicum and, to a lesser
extent S. mekongi, which occur in Asia (China, The
Philippines, and parts of Laos and Cambodia) are zoono-
tic, where water buffalos and other bovines were consid-
ered the major definitive hosts. In China, for example,
after five decades of concerted and multifaceted interven-
tions (including chemotherapy, mollusciciding, health
education, sanitation and environmental improvement),
S. japonicum remains endemic among humans (Zhou
et al. 2007) and has even re-emerged in areas where it
was thought to have been eliminated (Liang et al. 2006).
Novel analyses involving a combination of parasitological
field data, population genetics and mathematical mod-
elling using a framework that partitioned the contribu-
tions different host species made to the parasites basic
reproduction number (R0; see Box 1) demonstrated that
spill-over from animals is indeed maintaining human
schistosomiasis in China, and in the absence of such zoo-
notic reservoirs, human transmission could be inter-
rupted (Rudge et al. 2013). However, investigation of the
relative contribution of each host species demonstrated
that it was not only the previously implicated bovines
responsible for such zoonotic transmission, but that in
hilly regions where cattle are now rare, various rodent
species are responsible for maintenance of transmission
and spill-over to humans (Wang et al. 2006; Lu et al.
2009, 2010a,b, 2011; Rudge et al. 2009, 2013). These
results also showed that, as a zoonosis, S. japonicum
could be classified as either a spill-over pathogen, an
apparent multihost pathogen or a true multihost patho-
gen (Box 1), depending on the ecological location and
scale at which the multihost parasite community is
observed, all of which may have implications for any
subsequent control measures applied. This work also
highlighted that estimates of relative host species contri-
butions to overall transmission may be biased by differ-
ences in the ease with which they can be captured and
sampled; species with low capture probabilities might be
underrepresented, such that their role in transmission is
underestimated (Rudge et al. 2013; Streicker et al. 2013).
In the case of S. japonicum in China, there had been no
previous sampling recorded from rodent wildlife popula-
tions and hence this important potential reservoir host
had been ignored. Even if additional zoonotic control
measures such as the removal or vaccination of water
buffalo were applied, these may not be sufficient to inter-
rupt transmission, or even achieve sustainable control, if
rodents subsequently maintain transmission (Rudge et al.
2013). Similar challenges occur in the Philippines, where
parasitological and molecular analyses have revealed that
dogs are partially responsible for maintaining S. japon-
icum transmission and human infections (Rudge et al.
2008).
A conceptual framework for understanding host species
contributions to parasite transmission in a given ecological
setting may be helpful. As exemplified above, a parasite’s
fitness can be measured by its basic reproduction number,
R0, the number of new infections (for a microparasite, such
as a virus, bacteria or protozoan) or new adult parasites
(for a macroparasite, such as a helminth or ectoparasite)
arising from a primary infection in a wholly susceptible
host population or community (Anderson & May, 1991).
In a multihost species context, the overall R0 of the parasite
(R0,TOT) within a host community will depend on the sepa-
rate contribution of each host species (R0,i); only those spe-
cies with an R0,i > 1 will be capable of independently
sustaining transmission in the absence of other host species
(Fenton and Pedersen 2005; Funk et al. 2013; Fenton et al.
2015). Such a theoretical framework was applied by Rudge
et al. (2013) on the zoonotic S. japonicum, which allowed
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the different host species contributions to R0,TOT to be
quantified using relatively straightforward parasitological
data, and important conclusions about transmission and
the likely effects of control measures to be made.
The underlying drivers of heterogeneity among host spe-
cies in how they contribute to transmission, and evolution-
ary selective forces, also influence optimal control of
multihost parasites. Again using mathematical simulations,
Streicker and colleagues compared the efficacy of treating
infected vs. random individuals under contrasting key host
types, and demonstrated very different control implications
under each scenario (Streicker et al. 2013). If key hosts
arise through high abundance, it is potentially worthwhile
making the effort (if possible) to identify and remove only
infected key host individuals. In contrast, when key hosts
are rare but commonly infected, there may be few gains by
identifying infected individuals, and so treating (or in cer-
tain cases culling) all individuals regardless of infection sta-
tus is a more practical approach. Hence, the added
diagnostic costs of test-and-treat or test-and-cull programs,
as used to control bovine tuberculosis in African buffalo
for example (Jolles et al. 2005), might yield only trivial
gains over untargeted control for certain drivers of host
heterogeneity. In such circumstances, prioritizing maxi-
mization of treatment rates over accurate diagnosis may be
optimal, while test-and-treat strategies may be highly fruit-
ful in others zoonotic scenarios. In Uganda, for instance,
where cattle are the major reservoir of Human African Try-
panosomiasis caused by Trypanosoma brucei rhodesiense,
treatment of all cattle has been demonstrated to be a more
cost effective option than a test-and-treat approach and is
combined by selective spraying of cattle with insecticide
thereby reducing both the reservoir of human infection
and the vector population (Welburn et al. 2015).
Animal reservoirs and host switching in response
to changing selective pressures
Host switches, the process by which a parasite successfully
jumps from one host species to another (Box 1), are
thought to have been a major process in the evolution of
many zoonotic disease systems. In general, however, very
little is known about the ecology and even less the evolu-
tion of infectious agents of wildlife, livestock and even
companion animals relative to that of humans (Tomley
and Shirley 2009), and there are several examples where
enzootic viruses of animals (e.g. SARS coronavirus, han-
taviruses, Ebola and Marburg viruses, Nipah virus, Hendra
virus and human immunodeficiency viruses) were com-
pletely unknown until they switched hosts and caused dis-
ease in humans (Parrish et al. 2008). The evolutionary
potential of a parasite will affect its ability to infect a new
host species (Cleaveland et al. 2001; Antia et al. 2003) and
disease management methods such as chemotherapy may
provide sufficient selection pressure to drive host switching
by parasites (Fig. 1). Pathogens with high mutation rates,
antigenic diversity and short-generation times, for example,
may rapidly adapt to new host species (Whitlock 1996;
Gupta et al. 1998; Woolhouse et al. 2002), and evidence
suggests that RNA viruses are the most likely group of
infectious agents to host switch and establish in humans,
(Woolhouse et al. 2001). If selective pressures are suffi-
ciently strong, however, even organisms with very long
generations times, such as many helminth species, have
high potential for evolutionary change and host switching
(Woolhouse and Webster 2000; Woolhouse et al. 2002).
Epidemiological features of disease, routes or modes of
transmission, pathogen virulence evolution and host sus-
ceptibility may all influence a parasite’s ability to switch
host species.
More cases of potential reservoir hosts and host switch-
ing are likely to be detected as improvements in molecular
typing become available. An important example is the Gui-
nea worm Dracunculus medinensis, a parasitic worm trans-
mitted by infected copepods consumed when people drink
contaminated water. Guinea worm (Dracunculiasis) is cur-
rently targeted for global eradication via the Guinea Worm
Eradication Program (GWEP), through surveillance, case
containment, improved access to clean drinking water,
copepod control, provision of water filters, education and
behaviour change. In 2013, there were only 542 cases
reported in four counties (Chad, Ethiopia, Mali and South
Sudan), and by 2014, only 126, mainly in South Sudan
(Biswas et al. 2013). However, Dracunculiasis was redis-
covered in Chad in 2010 after an apparent absence of
10 years when no human cases were reported (Eberhard
et al. 2014). Furthermore, the epidemiologic pattern of the
re-emerged disease in Chad is unlike that seen previously
in Chad or other endemic countries, including those now
certified as free of transmission. Notably large numbers of
dogs were found to be infected in Chad. Molecular
sequencing, using both COX-1 barcoding and whole-gen-
ome sequencing (WGS) indicated these infections, human
and dog alike, were all caused by D. medinensis. It thus
appears that the infection in dogs is serving as the major
driving force sustaining transmission in Chad, with poten-
tially an aberrant life cycle involving a paratenic host
(Box 1) involved in transmission to both humans and dogs
(Eberhard et al. 2014). A life cycle which involves a parate-
nic host has been reported from Dracunculus insignis, a
parasite of racoons in North America, and in D. insignis
from ferrets in laboratory studies (Crichton and Beverly-
Burton 1977; Eberhard et al. 2014). It is postulated that
dogs have become infected by eating fish entrails which
have been discarded when fish are dried for later human
consumption, with fish acquiring infection from copepods
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and maintaining viable D. medinensis larvae. Such observa-
tions suggest that, rather than being eradicated in Chad,
Guinea Worm may have host switched from predomi-
nantly infecting humans to being a canine zoonotic infec-
tion (although due to a scarcity of rigorous sampling of the
canine populations previously, the possibility that they
have always harboured Guinea worm infections cannot be
ruled out). Dracunculus medinensis has also been occasion-
ally reported from cats, horses, cows, wolves, leopards,
monkeys and baboons (Genis 1972). Further research into
and monitoring of dogs, and ideally also cats and wildlife,
as viable hosts for this parasite, combined with further
WGS to elucidate potential selective pressures and host
shifts, are now required. Of concern is that the number of
cases of D. medinensis in dogs in Chad continues to esca-
late (Center 2015). Guinea worm was a parasite targeted
for global eradication in part because it was believed to be a
human parasite with no zoonotic reservoir. More broadly,
this Guinea worm example highlights a rarely considered,
general challenge for disease control programmes, that con-
trol efforts in one target host species (e.g. humans or live-
stock) may provide a selective pressure for parasites to
expand or shift their zoonotic host range, thereby enabling
them to be maintained in new reservoir host species
(Fig. 1).
There is also evidence from another helminth, Ancy-
lostoma ceylanicum, a hookworm of canids and felids in
Asia, of transmission from these animals to humans, even
in the era of human-targeted mass drug administration
against hookworm and other soil-transmitted helminths.
In a recent study which examined both humans and dogs
in a rural Cambodian village, over 57% of the human pop-
ulation was infected with hookworms and of those, around
half harboured A. ceylanicum. Over 90% of the dogs exam-
ined were also infected with A. ceylanicum. Furthermore,
characterization of the COX-1 gene subdivided the A. cey-
lanicum isolates into two groups, one containing isolates
from humans only and the other a mix of isolates from
humans and dogs. The authors proposed that human-tar-
geted chemotherapy alone, in the absence of concurrent
animal health programs, may have facilitated a host switch
and establishment of A. ceylanicum infections in humans
(Inpankaew et al. 2014).
Among schistosomes, while the Asian species S. japon-
icum and S. mekongi are accepted as zoonotic, there is evi-
dence that human S. mansoni has recently switched to
being maintained in nonhuman primates in areas of Africa,
such as the National Parks in East Africa, where human
hosts are no longer available (Muller-Graf et al. 1997).
Similarly, following extensive human-targeted control pro-
grammes, S. mansoni appears to have switched back
towards a murid definitive host (Rattus rattus) in Guade-
loupe, the French West Indies (Theron 1984; Theron et al.
1992). A study in Kenya, using COX-1 barcoding, revealed
that 6% of the rodents and insectivores sampled were
infected with a range schistosome species traditionally
believed to the livestock or human-specific, including
S. bovis and S. mansoni, in addition to their rodent schisto-
some species S. rodhaini (Hanelt et al. 2010). Although the
prevalence of S. mansoni infection in these reservoir popu-
lations was low (15%), as with S. japonicum in rodents
across China, these species have potentially vast population
sizes, giving them potential to be ‘super-abundant’ key
hosts, with implications for optimizing control measures
(Streicker et al. 2013). The potential role of these highly
abundant small wild animals in host switches and subse-
quent ongoing parasite transmission, particularly perhaps
following large-scale human chemotherapy programmes,
warrants further research.
Mixed species co-infections and introgressions
Multiparasite systems are evolutionarily as well as ecologi-
cally dynamic. Hence, effective disease control of NZDS
must consider not only how best to deal with reservoir
hosts and host switching, but also the possibility of novel
parasites evolving and establishing. Polyparasitism, that is
co-infection with more than one parasite species, is the
norm in animal populations, including humans, and par-
ticularly in the developing world (Mupfasoni et al. 2009).
For instance, across much of sub-Saharan Africa, humans
can be co-infected with S. mansoni and Schistosoma haema-
tobium (Webster et al. 2012; Garba et al. 2013), their
domestic livestock co-infected with S. bovis, S. curassoni
and/or S. mattheei (Rollinson et al. 1990), and rodent
wildlife co-infected with S. mansoni and S. rodhaini
(Hanelt et al. 2010). Through synergistic or antagonistic
(including competitive exclusion) interactions among par-
asites, co-infection may influence parasite establishment,
growth, maturation, reproductive success and drug efficacy
(Norton et al. 2008; Webster et al. 2008). Additionally, co-
infection by species belonging to the same genus can allow
heterospecific (between species) pairings, resulting in either
parthenogenesis (asexual reproduction where eggs occur
without fertilization) or introgression (the introduction of
genes from one species into that of another) and the pro-
duction of hybrid offspring (Box 1: Fig. 1). Introgression,
also known as introgressive hybridization, in genetics is the
movement of a gene (gene flow) from one species into the
gene pool of another by the repeated backcrossing of an
interspecific hybrid with one of its parent species (Box 1).
Introgression is an important source of genetic variation in
natural populations and may contribute to adaptation and
even adaptive radiation (Mavarez et al. 2006; Pardo-Diaz
et al. 2012). Introgression differs from simple hybridization.
Introgression results in a complex mixture of parental
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genes, while simple hybridization results in a more uniform
mixture, which in the first generation will be an even mix
of two parental species. Genetic exchange among parasite
species has potential implications for heterosis (hybrid vig-
our), the emergence and spread of novel and virulent
strains, differential sensitivity to chemotherapy, increased
host range and adaptation to new ecological niches that
may provide a selective advantage. While hybrid offspring
are usually sterile, recent molecular developments have
revealed instances of fertile hybridizations, or introgres-
sions, in plants, animals and occasionally parasites (Detwi-
ler and Criscione 2010; King et al. 2015), which could have
major impacts on species diversification and host range
(Consortium* 2012), infection persistence, drug resistance
and clinical outcomes, and poses further challenges for
effective control. In addition, pathogen evolution through
introgression may greatly affect the likelihood of disease
emergence by increasing the pathogen’s basic reproduction
number (R0). For example, avian influenza has emerged
several times in human populations since 1997. Typically,
limited human-to-human transmission exists, so that
although the avian reservoir and susceptible human popu-
lations are large, outbreaks are rare and isolated (Fenton
and Pedersen 2005). Only through recombination between
strains and acquisition of human-specific respiratory
epithelium receptors could the virus evolve sufficient trans-
missibility to be sustained in the human population, which
poses the greatest risk for pandemics (Webby and Webster
2003). These genetic changes could shift avian flu from
being a spill-over to becoming a true multihost parasite,
which would have serious implications for human health.
Evidence for hybridizations and introgressions between
parasite species is gathering, at least in part in line with
improvements in molecular diagnostics and genome
sequencing of these organisms. Examples include several
causative agents of important NZDS caused by helminths,
such as Schistosoma, Fasciola, Ascaris and Trichinella (Schis-
tosoma, Fasciola, Ascaris, and Trichinella; Criscione et al.
2007; Dunams-Morel et al. 2012; Le et al. 2008; Webster
et al. 2013a), protozoa, such as Plasmodium, Leishmania,
Toxoplasma and Trypanosoma (Akopyants et al. 2009;
Gaunt et al. 2003; Grigg et al. 2001; Machado and Ayala
2001; Ramiro et al. 2015; Rogers et al. 2014; Sturm et al.
2003), as well as their vectors (King et al. 2015). For
instance, research on A. lumbricoides and A. suum collected
from sympatric human and pig populations in both Guate-
mala and China found that between 4 and 7% of the
roundworms sampled were hybrids. Similarly, Yamane and
colleagues examined COX-1 and two nuclear genes in tape-
worms obtained from humans in the Tibetan Plateau of
Sichuan, China, where Taenia saginata, a parasite of cattle,
and T. asiatica, a parasite of both humans and pigs are sym-
patrically endemic (Yamane et al. 2012). Phylogenetic anal-
yses revealed that some adult worms showed nuclear-
mitochondrial discordance, suggesting they originated from
hybridization, and due to the nature of the discordance, that
reciprocal hybridization between T. saginata and T. asiatica
could occur. The authors concluded that although self-ferti-
lization, and hence, inbreeding are thought to be the main
reproductive mode of Taenia, heterozygosity at nuclear loci
suggested ongoing hybridization between T. asiatica and
T. saginata in many co-endemic areas. Furthermore, subse-
quent phylogenetic analyses by the same authors, using par-
tial sequences of the DNA polymerase delta (pold) gene,
revealed that adult worms previously identified as T. asiat-
ica using mitochondrial DNA, were homozygous for an
allele that differed from a T. saginata allele by a single
nucleotide substitution. Such results indicate that most
adult worms previously assumed to be T. asiatica were in
fact not actually ‘pure T. asiatica’ but instead originated
from the hybridization of between T. saginata and T. asiat-
ica (Yamane et al. 2013).
There is also an increasing literature on introgressions in
the protozoal NTDs leishmaniosis and trypanosomiasis
(Miles et al. 2009; Messenger et al. 2012, 2015). Approxi-
mately 30 000 people in 36 countries of sub-Saharan Africa
suffer from human African trypanosomiasis (HAT), which
is caused by either Trypanosoma brucei gambiense or Try-
panosoma brucei rhodesiense. The other human form of
human trypanosomiasis, Chagas disease, has been classed
as the most important vector-borne infection in Latin
America, affecting an estimated 7–8 million individuals
with around 21 000 deaths per year (WHO 2014). Leish-
mania parasites give rise to a spectrum of diseases ranging
from the dermal lesions of cutaneous leishmaniasis to the
organ failure of visceral leishmaniasis. While there are cur-
rently no known reservoir hosts of visceral leishmaniasis in
India, Nepal and Bangladesh, where the most serious mor-
tality occurs, both Leishmania spp. and Trypanosoma spp.
are parasites with arrange of major potential zoonotic
reservoirs, encompassing both domestic livestock and wild-
life (Table 1). For example, at least two of the six major lin-
eages (distant typing units) of T. cruzi (III & IV) are now
believed to have arisen by hybridization, despite their pre-
dominant mode of asexual reproduction, with lineages dif-
fering in their biology, drug sensitivity and host range
(Miles et al. 2009). Furthermore, evidence from laboratory
crosses of the HAT infectious agent T.b. rhodiesenses and
the morphologically indistinguishable nonhuman infective
subspecies T.b. brucei, involving sexual reproduction within
the tsetse fly vector, demonstrated that the Serum Resis-
tance Associated (SRA) virulence gene, which is the single
gene that governs human infectivity in T.b. rhodesiense, can
be transferred by genetic exchange to T.b.brucei strains,
thus creating new genotypes of potentially human infective
parasites (Gibson et al. 2015). The authors thus concluded
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that new strains of the human pathogen T.b. rhodiense are
likely to be being generated continuously by recombination
with the much larger pool of animal-infective try-
panosomes and that such novel recombinants present a risk
for future outbreaks of HAT.
Similarly, while asexual reproduction through clonal
propagation is thought to be the major reproductive mode
for Leishmania, a sexual cycle has been detected experimen-
tally within the sand fly vector, and sexual recombination
under a range of endemic field conditions has long been
suspected, based on hybrid marker profiles (Kelly et al.
1991; Rogers et al. 2014). For example, intraspecific
hybridization events between L. donovani clones in Ethio-
pia (Gelanew et al. 2014) and L. infantum clones in Tunisia
(Chargui et al. 2009), as well as interspecifically, for exam-
ple between the closely related L. braziliensis and L. guya-
nensis in Venezuala (Delgado et al. 1997) and the much
more widely divergent L. infantum and L. major where
hybrids were isolated from immune-compromised patients
in Portugal (Ravel et al. 2006). The potentially important
evolutionary and epidemiological consequences of such
events are highlighted by the observation that Leishmania
infantum:L. major hybrids possess enhanced transmission
potential, since unlike either of their parental single species,
hybrid offspring are able to infect an additional sandfly vec-
tor species, the geographically broader ranging Phlebotomus
papatasi (Volf et al. 2007).
Another topical example of the potential for introgres-
sion to affect disease transmission through changes in host
range is provided by S. haematobium, the causative agent
of urogenital schistosomiasis. Schistosoma haematobium
was believed to be an exclusively human-specific parasite
and the risk of zoonotic transmission in Africa was deemed
safe to ignore. However, as early as the 1940s there were
suggestions of potential hybridizations involving different
Schistosoma species, initial based on variable egg morpholo-
gies, but later, from the 1990s, using molecular tools such
as enzyme electrophoresis (reviewed in Leger and Webster
in press). More recently ITS1 + 2 and COX-1 studies of
schistosome miracidial larvae collected and successfully
hatched from the stool and urine of Senegalese school chil-
dren confirmed bidirectional hybridization between
S. haematobium of humans and S. bovis of livestock
(Huyse et al. 2009), and between S. haematobium of
humans and S. curassoni of livestock (Webster et al.
2013a). Similar studies on infected snail intermediate hosts
in Kenya, using microsatellite markers, rDNA and mtDNA,
also observed hybrid cercariae between S. mansoni of
humans and its sister species, S. rodhaini, of rodents
(Steinauer et al. 2008). Furthermore, these hybrids were
demonstrated to produce viable offspring through first and
successive generation backcrosses with S. mansoni. In this
case, however, the direction of introgression appeared
highly asymmetric, with unidirectional gene flow from the
rodent parasite, S. rodhaini, to the human parasite, S. man-
soni (Steinauer et al. 2008). Recent evidence from eggs and
miracidia from infected humans in Senegal have also
detected potential introgressions between the more phylo-
genetically distant S. haematobium and S. mansoni, pair-
ings between these two species that was previously believed
to result in unviable eggs exclusively through parthenogen-
esis (Huyse et al. 2013). Such evolutionary changes in these
parasite populations are likely to have major implications
in light of the current global push for human chemother-
apy control programmes to shift from controlling morbid-
ity to halting transmission. Further empirical work is now
necessary to confirm the epidemiological importance of
these hybridization events, for example to monitor how
their prevalence and genetic composition changes over
time, and in response to varying environmental conditions
and chemotherapy. Phylogenetic studies may identify
where and how these hybrids arise, and help predict where
they may arise in the future. A particularly pertinent ques-
tion is whether the evolution and expansion of zoonotic
hybrid schistosomes in Africa is a recent phenomenon in
response to new anthropogenic changes and pressures, in
particular the wide-scale treatment of human populations
with praziquantel, or simply recently detected through
improvements in molecular diagnostics. Evidence in favour
of the former may be provided by the observation that
hybrids have not been detected across all countries and
regions examined to date. For instance, no hybrid schisto-
somes have been detected in Zanzibar, despite extensive
molecular analytical studies being performed. There is
therefore a need to understand what drives the occurrence
of hybrids in some locations and not others. In the context
of current control efforts, there is a need to determine
whether the efficacy of praziquantel, the only currently
used antischistosome drug, differs for hybrid parasites, and
whether this could partly or wholly explain recent poor
responses to preventative chemotherapy in areas where
hybrids are prevalent. It is also important to understand
whether hybrid infections present a differential human
(and animal) morbidity profile, as a result of, for example,
either hybrid vigour and/or the hybridization of intestinal
with urogenital schistosome species (Koukounari et al.
2010; Gouvras et al. 2013)). Such differential morbidity in
hybrid infections may have major implications for current
methods of monitoring human morbidity levels and con-
trol programme efficacy. Finally, how such introgression
may alter host range, and hence, transmission potential is
perhaps the most pressing area for future research. Many
schistosome species infecting livestock have a broader geo-
graphical range beyond sub-Saharan Africa, where compat-
ible snail intermediate hosts are present. Novel zoonotic
hybrids may therefore have the potential to become not
© 2015 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd 9 (2016) 313–333 325
Webster et al. A one health approach to tackling the NZDs
simply an NTD, but more of a global disease, particularly
with global warming, increased human and animal move-
ment and transportation. The cattle schistosome S. bovis,
for example, has a naturally wide definitive host spectrum
and is compatible, at least experimentally, with a wide
range of intermediate snail host species (Mone et al. 1999).
In Europe, human urogenital schistosomiasis, associated
with S. haematobium, has previously been detected in Por-
tugal, where this focus disappeared during the 1950s (Fraga
de Azevedo et al. 1948). However, freshwater snails of the
species Bulinus contortus, B. truncatus and Planorbarius
metidjensis, which are recognized intermediate hosts for
S. haematobium, have been found in Portugal (de Azevedo
1969), Spain (Silva Oliveira et al. 1974; Perez-Quintero
et al. 2004) and Corsica (Gretillat 1963; Doby et al. 1966).
These findings suggest that urogenital schistosomiasis
could re-emerge and establish in southern Europe, if these
molluscs become infected. Furthermore, introgressed
hybrids between human S. heamatobium and livestock
S. bovis have recently been identified, with potentially sub-
stantial ongoing transmission among both local residents
and tourists, in Corsica, Europe (Berry et al. 2014; ECDC
2014; Boissier et al. 2015).
For all recently identified parasite introgressions, we now
need to identify in which host species the actual hybridiza-
tion events actually occur. Furthermore, if such hybridiza-
tions are maintained through successive generations, we
need to identify and distinguish between potential spill-
over and key hosts that are driving ongoing transmission.
For example, hybrids between human with animal Schisto-
soma spp. have, to date, only been identified in humans
and snail intermediate hosts, but future work must assess
the potential role of both livestock and wildlife. Identifying
parasite transmission events in livestock and wildlife popu-
lations is notoriously challenging. Nevertheless, future
quantitative and qualitative data sets and multihost R0
framework analyses on the occurrence and consequences of
hybridization and introgression would enable exploration
of the possible movement of any emerging potential hybrid
through that parameter space as it evolves, for instance,
towards generalist or specialist on the available host
species.
Potential uses of animal reservoirs in human
disease control
The NZDs, particularly those that infect livestock, pose
additional indirect risks to the health of human popula-
tions through their impact on livelihoods, poverty and
potentially nutrition. However, the role of zoonotic reser-
voirs in disease control need not be all entirely negative,
and their advantages versus disadvantages must be fully
understood. One potential upside is that disease control
in a key reservoir species, for example domestic animals,
may be more practical than in humans. New vaccines are
often easier and faster to develop for animal than for
human use, particularly in terms of safety and clinical
trial regulations. Moreover, targeting the animal reservoir
can also limit the number of new human cases and their
associated morbidity, which is particularly relevant for
diseases with a high mortality rate, or for which treat-
ment itself carries risks, such as trypanosomiasis. Spray-
ing cows with insecticide to control tsetse flies has, for
instance, been shown to be effective for the control of
T. rhodesiense –associated human African trypanosomiasis
(Welburn et al. 2001; Hargrove et al. 2012; Muhanguzi
et al. 2014). Furthermore a combined approach of
chemotherapy in cattle as well as spraying cattle with
insecticide has been shown to be particularly effective in
Uganda, where cattle movement threatens the spread of
T. rhodesiense into areas endemic for the chronic form of
the disease in the north-western parts of the country
(Hargrove et al. 2012) (Hargrove et al. 2012).
Alternative host species may also play a role in reducing
infection risk through the ‘dilution effect’ (Keesing et al.
2006). In this scenario, host species that had low capacity
for onward transmission may ‘absorb’ or disrupt infectious
contacts, thereby reducing the force of infection on a target
host species. This has been classically thought of in terms
of tick-borne diseases (e.g. Lyme disease), where infection
opportunities are lost through ‘wasted bites’ by ticks on
noncompetent host species. Although there is considerable
debate about the generality of this phenomenon (Randolph
and Dobson 2012; Wood et al. 2014) and the mechanisms
may be complex and hard to disentangle (Salkeld et al.
2013; Strauss et al. 2015), evidence is accumulating to sup-
port it in a number of systems (Civetello et al. 2014) sug-
gesting that increased biodiversity can be beneficial in
terms of reducing infection risk, at least in some circum-
stances.
Animal reservoirs may also have a positive role in the
context of reducing the risk of drug resistance evolving. It
is suspected that one reason praziquantel resistance has not
established in China, despite extensive preventive
chemotherapy for schistosomiasis, is the existence of ani-
mal host reservoirs, and hence large Refugia (Box 1) for
parasites. Should there also be large domestic and/or wild
animal reservoirs for the African human schistosomes (a
possibility that requires further investigation), this could
actually mitigate against the establishment or spread of
praziquantel resistance in these areas. The relative impor-
tance of nonhuman hosts as both sources of infection, and
conversely as Refugia, will, however, depend on whether
the parasite population is panmictic or whether different
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parasite strains circulate independently in different host
species, that is whether parasites are partial or wholly cov-
ert host specialists. Drug selection pressures are also sus-
pected to differ between parasite species, with potential
implications both for and against the potential emergence
of praziquantel resistance (Webster et al. 2008).
While zoonotic infections may be harder to eliminate
due to the presence of animal reservoirs driving transmis-
sion, other processes may select for reduced human infec-
tion. If parasite strains vary in host preference, selection
imposed by drug treatment in humans may lead to a shift
in host preference, favouring strains that prefer nonhuman
hosts. Observations from Guadeloupe suggest such a pro-
cess may have occurred in S. mansoni there. Phenotypic
and genetic studies suggest the recent adaptation of
S. mansoni (back) to its rodent host has resulted in a phe-
notypic change (the time of cercarial emergence), that may
decrease the risk of human infection (Theron 1984; Theron
et al. 1992). Even in a country as large as China, there is
evidence that some genetic and phenotypic isolation may
be occurring, with a more rodent-philic S. japonicum being
selected (Wang et al. 2006; Lu et al. 2009, 2010a,b, 2011;
Rudge et al. 2009, 2013). Further, it appears S. japonicum
in China may show local adaptation to the use of different
definitive host reservoirs; in hilly regions where nocturnal
rodents predominantly maintain transmission, cercariae
are being shed from Oncomelanaia snails in the late after-
noons and evening, while in lowland habitats where bovi-
nes drive transmission, early morning shedding occurs,
which coincides with the timing of peak bovine water con-
tact (Lu et al. 2009, 2011). Such patterns may be the conse-
quence of intense human chemotherapeutic pressure in
China, selecting increasingly zoophilic parasites. This raises
the question of what may happen when drug-imposed
selective pressure ceases. The answer may depend on the
extent of parasite divergence by the time this pressure is
removed. If no genetic isolation has evolved between para-
site genotypes circulating in humans and animals, one
would predict continued transmission to humans and re-
establishment as a human disease. This situation may be
relevant currently for S. japonicum in the Philippines
(Rudge et al. 2008) and China (Rudge et al. 2009), where,
although adaptation towards different host species does
appear to be occurring, species-specific private alleles (alle-
les found only in a single population) appear to be
circulating across both human and animal hosts. However,
if complete or near complete genetic isolation between par-
asites in animal and human hosts occurs, one could predict
the evolution of an exclusively zoophilic parasite. Findings
from Taiwan may indicate such an outcome, where
although S. japonicum continues to infect a broad range of
animals, it now appears unable to infect humans (Fan
2006).
Ecological and evolutionary applications –
optimizing disease control for NZDs
We live in a time where disease ‘elimination’ and even ‘erad-
ication’ have been proposed as Millennium Development
Goals (WHO 2012b). These goals are difficult to achieve for
any infectious disease, as reflected by the fact that only one
human and one animal pathogen have been globally eradi-
cated to date (smallpox and rinderpest; (Klepac et al. 2013).
The challenges of elimination are magnified for zoonotic
parasites (Taylor et al. 2001). To eliminate zoonotic infec-
tions, one must not only eliminate infection in the human
population, but also prevent or eliminate transmission from
animal reservoirs. Moreover, parasite evolution occurs
across multiple hosts. This added ecological and evolution-
ary complexity has key implications for designing effective
disease control strategies. For example, infection control
may need to target multiple host species, or block transmis-
sion pathways between animals and humans. Moreover, the
set of tools required for control are likely to be more diverse
for zoonoses. These parasites may show genetic diversity
across different host species, such that a vaccine or drug
effective in one host species, may not be in another. More-
over, drug treatment of animal reservoirs, even with differ-
ent drugs to those used in humans, may lead to the
development of cross-resistance, rendering human drug
treatment less effective (Maia et al. 2013). Simply expanding
control measures used in humans to animal reservoirs may
often not be the best solution (Maia et al. 2013). Evidence-
based strategies that exploit a sound understanding of each
NZD’s ecology and ongoing evolution are likely to be more
fruitful. While elimination of most NTDs with zoonotic
reservoirs may be aspirational rather than realistic at present,
good progress continues to be made on the control of several
important NTDs, and mechanisms are now in place to bring
together the critical scientific expertise and political will to
significantly improve control of NZDs.
Typically, zoonotic diseases are managed, if at all,
through separate interventions across the human and ani-
mal health sectors. However, there is a clear public health
imperative for approaches that take into account the full
One Health perspective, by understanding the transmis-
sion ecology and evolution of NZDs across all hosts they
infect, both animal and human. Each NZD is likely to be
different, with optimal control depending on (i) exactly
which animals contribute to transmission and in what
way; (ii) the particular routes of animal‒human transmis-
sion; and (iii) known evolutionary changes occurring in
the parasite that may affect for example parasite popula-
tion genetics and host range or response to control mea-
sures. Given the global health agenda and widespread
scaling up of NTD control programs (Boatin et al. 2012;
Lustigman et al. 2012), studies that elucidate the complex
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transmission ecology of NZDs are especially timely. Evolu-
tionary theory has a role to play in informing NZD con-
trol programme design. Perhaps its most important role
will be to help predict how treatment imposed selection
may drive evolutionary change in NZDs, thereby facilitat-
ing the design of effective monitoring processes, capable
of detecting such changes as they occur.
Successful NZD control is likely to involve state-of-the-art
approaches for diagnosis and surveillance across humans
and animal hosts, to provide a network of global intelligence
on their distribution, potential for spread, and disease bur-
den. Control of NZDs calls for integrated collaboration
among governments and nongovernmental organizations
engaged at the human–animal–ecosystems interface,
between researchers from medical, evolutionary, ecological
and social fields, and strengthening information exchange
across relevant sectors in affected countries, particularly agri-
culture and human health.
Ultimately, to impact policy for any given NZD, we first
need a sound empirical evidence base concerning multihost
transmission ecology, behaviour, morbidity, drug efficacy
and potential evolutionary changes such as introgression
occurring in different host species. This empirical evidence
then needs to be allied with robust theoretical and compu-
tational methods to understand the drivers of transmission,
and explore alternative disease management scenarios. We
make the following specific recommendations on what is
needed to successfully tackle both ancient and emerging
NZDs in the future:
1 We need a detailed empirical understanding of the biol-
ogy and relative importance of each key host species.
This involves not only understanding how to reliably
identify key host species within multihost parasite sys-
tems, but also the magnitude and precise nature of their
contribution to transmission, which may involve a vari-
ety of processes (Fenton and Pedersen 2005).
2 We need improved cutting-edge genetic and genomic
tools to differentiate infectious agents, across both spe-
cies and strain level. Such tools will enable researchers to
track the gene flow of key infectious agents, for instance
between wildlife, domestic animals and humans, as well
as reveal, for instance, novel host switching and intro-
gression events that are currently missed with existing
tools unless they involve recombination between very
different genetic backgrounds.
3 We need the development of methods for high quality
behavioural tracking of hosts that can characterize in
unprecedented detail their social networks and the barri-
ers and conduits for spread within and between species.
4 The application of novel mathematical and statistical
approaches from the fields of statistical, computer
science and network analysis will be important in order
to model gene flow across such multihost parasite trans-
mission networks and to provide a quantitative under-
standing of transmission ecology for multihost parasites.
Furthermore, molecular studies combined with mathe-
matical modelling using an R0 framework will be critical
to identify key hosts and hence identify targets for con-
trol. Such modelling will require empirical evidence on
factors such as differential pathogen susceptibility to
control measures (e.g. drug susceptibility), patterns of
interaction between humans, livestock and wildlife, and
integration with data collected from other sources such
as livestock numbers. Ideally we should also look to
extend these frameworks to explore potential evolution-
ary responses of the parasites to imposed control mea-
sures, for example to understand the likely impacts of
different control measures on patterns of parasite evolu-
tion including drug resistance and hybridization.
5 Finally, if we are to fully understand the impact of NZDs
on human disease as well as how relationships between
the causative parasites and their hosts may be changing,
we need to stress the importance to policy makers of
incorporating each of the above into expanded monitor-
ing and evaluation components inherent in all human
and animal disease control efforts.
The notable parasitologist Claude Combes stated ‘Tell
me what parasites you have and I’ll tell you who you are’
(Combes 2005). However, as our global environment
changes, including changes in livestock practices and the
selective pressures imposed by drugs and vaccinations,
combined with rapidly developing molecular tools allowing
finer scale identification of species and species complexes,
it is possible that additional parasites may ‘emerge’, and
our disease monitoring and prevention efforts will have to
continuously adapt if we are to effectively control them.
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